Categories
Resources
Your Recalls
Loading...
Get email alerts when new recalls match your interests.
Chemical contamination: presence of benzene
CGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits.
Super-Potent Drug: Out of specification potency results were obtained.
CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.
Defective Container: blister packs not properly sealed resulting in tablets being loose in the carton.
Lack of Assurance of Sterility
Labeling; Label Mixup; some bottles have an incorrect back label indicating 91% Isopropyl Alcohol
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit.
Contains undeclared and unallowed colors (Blue 1, Red 40, Acid Red 18)
Presence of foreign substance: Presence of Benzene.
Failed Dissolution Specifications
Chemical Contamination: This recall has been initiated due to detected trace levels of benzene.